Found 5 matching trials
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) PHASE3 The purpose of this study is to assess how bleximenib and Venetoclax (VEN)+...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) PHASE1 The purpose of this study is to determine the recommended Phase 2 dose(s) (...
Show More Learn More & Join Trial
A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies PHASE1 The purpose of this study is to determine the recommended Phase 2 dose (RP2...
Show More Status
Active Not Recruiting
Location
The University of Alabama at Birmingham
Learn More & Join Trial
A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia PHASE1 The purpose of this study is to assess how the body absorbs, breaks down (m...
Show More Location
The Christie NHS Foundation Trust Christie Hospital
Learn More & Join Trial
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML) PHASE3 The current standard of care treatment for adult patients with acute myeloi...
Show More Location
US-San Francisco CA-UCSF
Learn More & Join Trial